Research progress in diagnosis and treatment of HPV-associated oropharyngeal squamous cell carcinoma.
10.13201/j.issn.2096-7993.2023.09.009
- Author:
Meilin HE
1
;
Junlin YI
1
Author Information
1. Department of Radiation Oncology National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College，Beijing，100021，China.
- Publication Type:Journal Article
- Keywords:
HPV-associated oropharyngeal cancer;
diagnosis;
oropharyngeal carcinoma;
prognosis;
treatment strategy
- MeSH:
Humans;
Papillomavirus Infections/diagnosis*;
Quality of Life;
Squamous Cell Carcinoma of Head and Neck/therapy*;
Head;
Human Papillomavirus Viruses;
Oropharyngeal Neoplasms/therapy*;
Head and Neck Neoplasms
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2023;37(9):734-739
- CountryChina
- Language:Chinese
-
Abstract:
Oropharyngeal carcinoma is one of the most common malignant tumors of head and neck. In recent years, the incidence of Human papilloma virus-associated oropharyngeal squamous cell carcinoma（HPV-OPSCC） has been increasing year by year. With the advancement of minimally invasive surgical techniques, the wide application of intensity modulated radiation therapy, and the demand of patients for organ function protection and higher quality of life, the unique biological behavior and better prognosis of HPV-OPSCC have led to the exploration of a series of attenuated treatment modes. This article reviews the diagnosis and treatment status of oropharyngeal cancer and related research progress based on relevant reports.
